Nepicastat

This classification denotes an enzyme inhibitor with the molecular formula C14H15F2N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VPG12K4540, chemically known as 5-(aminomethyl)-1-((s)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthyl)-4-imidazoline-2-thione but generally known as nepicastat, which bears US NIH Compound Identifier 6367078. European Medicines Agency schedules Nepicastat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09199MIG. The term NEPICASTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). NEPICASTAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nepicastat under HS 29332990 and SITC 51573. As of Q4 2014, NEPICASTAT remains the US FDA Preferred Term for this commodity. Nepicastat bears US NLM identifiers UMLS ID C0668779 and NCI Concept Code C84003. SMILES: S=C1[NH](C2CCC3C(C2)CC(F)CC3F)C(=CN1)CN.